Results for tag: "Lyme Disease Drug"

The Lyme Disease Drug market is a subset of the Immune Disorders Drugs market. Lyme Disease is a bacterial infection caused by the Borrelia burgdorferi bacteria, which is transmitted to humans through the bite of an infected tick. Lyme Disease is the most common vector-borne disease in the United States and Europe. Treatment for Lyme Disease typically involves antibiotics, which can be administered orally or intravenously. The Immune Disorders Drugs market is a rapidly growing market, driven by the increasing prevalence of autoimmune diseases and the growing demand for treatments. The market is expected to grow at a steady rate over the next few years, driven by the increasing prevalence of autoimmune diseases and the growing demand for treatments. Companies in the Lyme Disease Drug market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Johnson & Johnson. Show Less Read more